Comparison of T-DM1 and trastuzumab-pertuzumab in HER2-positive breast cancer patients with residual disease after neoadjuvant therapy: a retrospective study by Junxiao Wang, Yushuai Yu, Qisheng Lin, Xin Wang

Get full text

Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy? by Ruiliang Chen, Yushuai Yu, Weiwei Chen, Wenfen Fu, Chuangui Song, Jie Zhang

Get full text

Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer by Qing Wang, Yushuai Yu, Liqiong Ruan, Mingyao Huang, Wei Chen, Xiaomei Sun, Jun Liu, Zirong Jiang

Get full text

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer by Wei Chen, Yushuai Yu, Chenxi Wang, Zirong Jiang, Xiewei Huang, Yidan Lin, Hongjing Han, Qing Wang, Hui Zhang

Get full text

Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer by Yidan Lin, Yushuai Yu, Qing Wang, Kaiyan Huang, Shukai Guo, Jie Zhang, Yihui He, Xin Yu, Jiwen Zhang, Fan Meng, Shicong Tang, Junhui Yuan, Chuangui Song

Get full text